CPT 87627: Multiplex Joint-Space Pathogen and Resistance Panel - OpenPayer

Summary & Overview

CPT 87627: Multiplex Joint-Space Pathogen and Resistance Panel

CPT code 87627 represents a comprehensive multiplex molecular assay that detects 26 or more pathogens and drug resistance genes from joint-space specimens, such as synovial fluid. Nationally, this code enables reporting for high-complexity laboratory testing used in evaluation of suspected septic arthritis and prosthetic joint infections, where rapid, broad-spectrum pathogen and resistance detection can inform clinical decision making and infection control.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the clinical purpose and laboratory setting for the test, guidance on typical billing context, and what to expect in payer coverage discussions. The publication addresses benchmarking considerations for utilization and reimbursement, highlights policy and coding updates affecting molecular multiplex assays, and situates the test within clinical workflows for joint infections.

This summary is written for a national audience and focuses on clinical and billing relevance: how the test is reported using CPT code 87627, its role in diagnosing joint-space infections, and the payer landscape that commonly governs coverage decisions.

AetnaBlue Cross Blue ShieldCigna HealthUnitedHealthcareMedicare87627CPTmolecular-diagnosticsmultiplex-assayjoint-infectionsynovial-fluidlaboratory-testingantimicrobial-resistance

Billing Code Overview

CPT code 87627 describes a laboratory multiplex nucleic acid amplification and probe hybridization test that detects 26 or more pathogens and drug resistance genes from a specimen collected from a joint space, such as synovial fluid from the knee or hip. The assay identifies multiple microbial targets and resistance markers in a single run, providing broad pathogen detection for suspected septic arthritis or prosthetic joint infection.

Service Type: Laboratory diagnostic testing — multiplex molecular assay

Typical Site of Service: Clinical laboratory or hospital laboratory processing synovial fluid or other joint-space specimens

Data not available in the input for modifiers, associated taxonomies, ICD-10 diagnoses, related codes, and service line.

Clinical & Coding Specifications

Clinical Context

A 62-year-old patient presents with an acutely swollen, painful knee after recent joint replacement surgery. The orthopedic surgeon obtains synovial fluid via arthrocentesis for diagnostic evaluation. Because prosthetic joint infection is a major concern, the synovial fluid specimen is sent to the microbiology laboratory for an expanded molecular panel that detects multiple bacterial, viral, fungal pathogens and common antimicrobial resistance genes. The lab performs a multiplex nucleic acid amplification and probe hybridization assay that screens for 26 or more pathogens and resistance markers from the joint-space specimen. Results guide targeted antimicrobial therapy and surgical decision-making (e.g., debridement, implant retention, or revision). Typical workflow: specimen collection in the clinic or OR, transport to the microbiology lab, accessioning, nucleic acid extraction, multiplex amplification and detection, result verification by a laboratory analyst, and reporting to the ordering orthopedic surgeon and infectious disease consultants.

Coding Specifications

Modifier	Description	When to Use
`26`	Professional component	Use when billing only the professional interpretation/analysis portion of the test separated from the technical component.
`TC`

CPT 87516: Hepatitis B Virus Nucleic Acid Probe Test

cpt-87581-mycoplasma-pneumonia-nucleic-acid-probe-test

CPT 87581: Mycoplasma pneumoniae Nucleic Acid Probe Test

cpt-87593-orthopoxvirus-nucleic-acid-probe-test

CPT 87593: Orthopoxvirus Nucleic Acid Probe Test

cpt-87528-herpes-simplex-virus-direct-nucleic-acid-probe

CPT 87528: Herpes Simplex Virus Test by Direct Nucleic Acid Probe

cpt-87468-anaplasma-phagocytophilum-nucleic-acid-detection

CPT 87468: Anaplasma phagocytophilum Nucleic Acid Detection

cpt-87337-entamoeba-histolytica-antigen-immunoassay

CPT 87337: Entamoeba histolytica Antigen Immunoassay

cpt-87530-herpes-simplex-virus-nucleic-acid-probe

CPT 87530: Herpes Simplex Virus Detection by Nucleic Acid Probe

cpt-87510-gardnerella-vaginalis-nucleic-acid-probe

CPT 87510: Gardnerella vaginalis Nucleic Acid Probe Test

cpt-87483-multiplex-cns-pathogen-detection-molecular-test

CPT 87483: Multiplex CNS Pathogen Detection, Molecular Test

cpt-87495-cmv-direct-nucleic-acid-probe

CPT 87495: Cytomegalovirus Detection by Direct Nucleic Acid Probe

Showing 1–10 of 167

Taxonomy Code	Specialty	Notes
`207X00000X`	Orthopedic Surgery	Ordering clinicians for joint aspiration, prosthetic joint management.
`207L00000X`	Infectious Disease	Orders and interprets advanced pathogen testing for complex infections.
`360200000X`	Clinical Laboratory	Laboratory directors and clinical laboratory scientists performing molecular diagnostics.
`207RC0000X`	Rheumatology	Evaluates non-implant inflammatory arthropathies that may prompt synovial testing.
`2080P0003X`	Emergency Medicine	May perform arthrocentesis and order urgent synovial pathogen testing in acute presentations.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`M00.86`	Other staphylococcal arthritis, multiple sites	Staphylococcal species are common causes of septic arthritis and are included in broad pathogen panels.
`M00.9`	Pyogenic arthritis, unspecified	General diagnosis prompting synovial fluid analysis for bacterial pathogens and resistance markers.
`T84.5XXA`	Infection and inflammatory reaction due to internal joint prosthesis, initial encounter	Prosthetic joint infection is a key indication for comprehensive molecular testing of synovial fluid.
`M65.9`	Synovitis and tenosynovitis, unspecified	Inflammatory presentations where molecular testing helps differentiate infectious versus noninfectious causes.
`M00.2`	Pneumococcal arthritis	Specific bacterial etiologies (e.g., Streptococcus pneumoniae) are targets of multiplex pathogen assays.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`20610`	Arthrocentesis, aspiration and/or injection, major joint or bursa (e.g., shoulder, hip, knee) without ultrasound guidance	Performed to obtain synovial fluid specimen for the multiplex molecular assay.
`88112`	Cytopathology, body fluids, except respiratory, non-gynecological; manual differential cell count and/or cell block preparation	May be performed on synovial fluid to evaluate inflammatory cells and aid diagnosis alongside molecular testing.
`87070`	Culture, bacterial; aerobic, with isolation and presumptive identification of isolates	Traditional synovial fluid bacterial culture often ordered in parallel with molecular multiplex testing.
`87471`	Infectious agent detection by nucleic acid (DNA or RNA), amplified probe technique, single organism; Chlamydia trachomatis	Example of organism-specific NAAT codes; multiplex assay consolidates detection of multiple organisms that would otherwise be billed separately.
`87252`	Smear, primary source with interpretation; Gram or Giemsa stain	Rapid Gram stain of synovial fluid is commonly performed at the time of arthrocentesis to provide immediate information while awaiting molecular results.

OpenPayer